Search

Search Constraints

You searched for: Author/Creator Méjean, Arnaud

Search Results

1. A germline mutation in PBRM1 predisposes to renal cell carcinoma. Issue 6 (24th April 2015)

2. Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France. (25th March 2019)

4. Bladder preservation in older adults with muscle-invasive bladder cancer: A retrospective study with concurrent chemotherapy and twice-daily hypofractionated radiotherapy schedule. Issue 7 (September 2022)

5. External Validation of a Predictive Model to Estimate Renal Function After Living Donor Nephrectomy. Issue 11 (November 2021)

6. MP47-02 MACHINE LEARNING APPROACH TO PREDICT PT3A UPSTAGING OF CLINICALLY LOCALIZED RENAL CELL CARCINOMA AND ONCOLOGICAL OUTCOMES AFTER SURGERY (UROCCR 15 STUDY). (May 2022)

7. National prospective study on the use of local haemostatic agents during partial nephrectomy. (31st October 2013)

9. Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial. Issue 5 (May 2022)

10. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. Issue 4 (12th March 2011)